Mice Model a Silent Killer

EARLY LESIONS:© 2003 Cold Spring Harbor Laboratory PressEarly stage pancreatic lesions in Pdx1-Cre; LSL-Kras; Ink/Arflox/lox animals. (A) A low-grade PanIN lesion. (B) A low-grade preinvasive ductal lesion. (C) A high-grade preinvasive ductal lesion. (D) Early focus of pancreatic adenocarci-noma with both ductal and anaplastic components. (E) A high-grade PanIN lesion with no adenocarcinoma foci. (F) A high-grade PanIN lesion (asterisk) surrounded by anaplastic tumor cells.Aquiet killer, pa

Written byAileen Constans
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

© 2003 Cold Spring Harbor Laboratory Press

Early stage pancreatic lesions in Pdx1-Cre; LSL-Kras; Ink/Arflox/lox animals. (A) A low-grade PanIN lesion. (B) A low-grade preinvasive ductal lesion. (C) A high-grade preinvasive ductal lesion. (D) Early focus of pancreatic adenocarci-noma with both ductal and anaplastic components. (E) A high-grade PanIN lesion with no adenocarcinoma foci. (F) A high-grade PanIN lesion (asterisk) surrounded by anaplastic tumor cells.

Aquiet killer, pancreatic cancer often eludes detection until it has progressed to late-stage metastatic disease. This is largely due to the organ's location in the body, which makes it difficult for physicians to evaluate. "You can't feel it with your hands, you can't palpitate it on an examination. There is no pap smear or mammogram for the pancreas, or PSA test. ... So when people present with pancreatic cancer, usually their symptoms are very nonspecific," says David Tuveson, assistant professor of hematology and oncology at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies